M42’s National Reference Laboratory (NRL) has entered into a strategic partnership with Abbott to support the introduction of innovative early cancer detection solutions in the UAE, using advanced diagnostic solutions based on biomarker testing and multi-marker algorithm-driven analyses. The partne. .



